• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

McKesson Could Move Higher So Trade It From the Long Side

MCK is a Covid vaccine distribution play.
By BRUCE KAMICH
Nov 24, 2020 | 01:35 PM EST
Stocks quotes in this article: MCK

Investors looking to play the distribution of a Covid vaccine should consider McKesson (MCK) , Jim Cramer told viewers of Mad Money Monday evening. Let's check out the chart of this company that distributes pharmaceuticals and provides health information technology, medical supplies, and care management tools.

 
In this daily bar chart of MCK, below, we can see that prices have broken out on the upside of a triangle formation that started back in May. MCK is trading above the rising 50-day moving average line and the rising 200-day moving average line.
 
Trading volume has been flat/neutral and so has the On-Balance-Volume (OBV) line.
 
The Moving Average Convergence Divergence (MACD) oscillator is above the zero line in bullish territory but it has crossed to the downside for a take profits sell signal. 
 
 
 
In this weekly bar chart of MCK, below, we can see the past four years of price action. MCK is breaking out to new highs for the move up.
 
The slope of the 40-week moving average line is positive.
 
The OBV line is steady and the MACD oscillator is bullish.  
 
 
 
In this daily Point and Figure chart of MCK, below, we can see a potential upside price target in the $202 area. 
 
 
Bottom line strategy: Trade MCK from the long side risking below $165. The $200 area is our first price target for now.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare | Mad Money | Coronavirus

More from Investing

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

Bob Lang
Aug 14, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

This Small Advertising-Tech Stock Could Offer a Big Opportunity

Bret Jensen
Aug 14, 2022 7:00 AM EDT

Let's check a covered-call play in PubMatic.

To Improve Your Trading and Investing, Spend More Time on Exit Points

James "Rev Shark" DePorre
Aug 13, 2022 10:00 AM EDT

For many investors, the best way to sell is to have a highly mechanical system that removes subjectivity.

Royal Investing: 3 High Yield Dividend Aristocrats

Bob Ciura
Aug 13, 2022 7:00 AM EDT

Here are the three highest yielding Dividend Aristocrats available right now.

Market Whips Up a Melt-up

James "Rev Shark" DePorre
Aug 12, 2022 4:21 PM EDT

This action is primarily caused by poor positioning, rather than a sudden improvement in fundamentals.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • 01:44 PM EDT STEPHEN GUILFOYLE

    This Holding Lights Up With Strong Earnings

    Check out the latest from TheStreet's Stocks Under...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login